1H revenue of Fosun International increased 12.1% YoY to RMB97.84bn, with overseas revenue at 47%.

Fosun International reported 1H revenue of RMB97.84bn, a 12.1% increase YoY, with 4 core subsidiaries contributing RMB72.17bn. Overseas revenue reached RMB45.87bn, 47% of total revenue. Fosun Pharma's revenue grew 5.31% to RMB20.46bn, with gross profit margin enhanced by 1.72 ppts. The company's debt-to-capital ratio fell to 50.2% and cash balances increased by RMB17.1bn. Fosun has a global presence in 35+ countries and is investing RMB3.5bn in tech innovation.

August 28, 2024
142 Articles